We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for healthcare professionals on blood clotting following COVID-19 vaccination.
Leaflet for people eligible for COVID-19 vaccination who have had their first dose of AstraZeneca vaccine and have concerns about having the second dose.
The government's plan for managing COVID-19 through the winter.
How to classify and manage people who have been exposed to CCHF.
Scientific advice queries on nanomedicines have increased in recent years, particularly on lipid nanoparticles.
Information for pregnant women to understand what it means to be a delta beta thalassaemia.
Updates from MHRA on the suspension of devices made by Silimed
This table sets out the 2022 to 2023 data for the local diabetic eye screening (DES) services in England.
This guidance explains the management of the cohort (people on the programme register) for the NHS diabetic eye screening (DES) programme.
This guidance sets out the data which diabetic eye screening (DES) services must submit nationally and the related dataset that provider IT systems require.
Explains the NHS Diabetic Eye Screening (DES) Programme's processes for image capture exceptions and ungradable images.
Instructions on how to submit key performance indicator (KPI) data for the NHS Diabetic Eye Screening (DES) Programme.
Information about 1,2-dichloroethane for use in responding to chemical incidents.
Laboratory guidelines for the diagnosis of infections caused by Corynebacterium diphtheriae and C. ulcerans.
Information relating to the disapplication of falsified medicines under UK Law.
Information on the reasons behind human infectious disease emergence, including a timeline and a global map.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
A guide to support the implementation of NICE Guidance (CG71) on the identification and management of familial hypercholesterolaemia.
Flood-health action cards summarise the suggested health-related actions that organisations should take to prepare for, respond to and recover from flooding.
These previous directions, published for public reference, were for the NHS from the Secretary of State for Health and Social Care and relate to payments for primary medical services contractors.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).